As more and more people receive medicinal cannabis prescriptions, we’re left with a system that is misaligned with its original purpose.
Articles on CBD oil
Displaying all articles
One in five people experience chronic pain. Here’s how likely you are to find relief with medicinal cannabis.
CBD isn’t a miracle cure for everything that ails a person – but science shows that it has the potential to help treat a number of health conditions.
A new study emphasises the huge potential and environmental benefits of hemp production and provides a road map to develop the nascent industry across the UK.
Policy-makers and stakeholders in Canada should re-examine CBD policies and ensure they are protecting, rather than confusing, consumers.
The TGA gave low-dose cannabis sales without prescription the green light in February. But no product has jumped through all the regulatory hoops to market yet.
Non-intoxicating cannabis products are safe and well tolerated by those who use them, so why not lower the clinical threshold for their manufacture and sale?
Cannabidiol, or CBD, is being touted in popular culture as a miracle cure-all. From creams to gummies and more, CBD has exploded onto the health scene. But what does the science actually say?
Government data suggest medical cannabis availability improved after legalization in Canada. But producers have struggled to meet demand for recreational cannabis other than oils.
Medical cannabis in the UK? Don’t hold your breath.
Cannabis, medical marijuana and CBD oil explained.
Top contributors
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Postdoctoral Research Associate, University of Exeter
-
Clinical pharmacologist, University of Newcastle
-
Professor of Operations Research, Brock University
-
Professor, Senior economist and team leader Food Marketing Research, Scotland's Rural College
-
PhD candidate, College of Health, Te Kunenga ki Pūrehuroa – Massey University
-
Assistant Professor, Faculty of Business Administration, Memorial University of Newfoundland
-
Professor of Policy and Health, Te Kunenga ki Pūrehuroa – Massey University
-
Professor of Medicine and Chair of Clinical Pharmacology, University of Newcastle
-
Professor and Chair of Pharmacology, Penn State
-
Associate Professor in Drug Policy and Health Law, Te Kunenga ki Pūrehuroa – Massey University
-
Project Coordinator, Marketing and Communications, Memorial University of Newfoundland
-
Professor and Chair of Pharmacodynamics, University of Florida
-
Assistant Professor of Pharmacodynamics, University of Florida
-
Research Assistant, Faculty of Business Administration, Memorial University of Newfoundland